Schoenherr and Sweden's Delphi law firm have advised AddLife on its acquisition of all shares in the DACH Medical Group Holding AG. The unidentified sellers were advised by SCWP Schindhelm.
Addlife is a Swedish Medtech company that is listed on the Nasdaq Nordic Exchange. According to Schoenherr, the company "is an independent operator in the Life Sciences industry that offers high-quality products, services and consulting in both the private and public sectors, mainly in the Nordic region and throughout the rest of Europe. The group has annual sales of approximately SEK 4.1 billion (approximately EUR 400 million).” The firm also reports that “DACH Medical Group Holding AG is the parent company of DACH Medical Group with net sales of approximately EUR 14 million, with operations in the advanced surgery product area with headquarters in Switzerland, Austria, and Germany. It markets and sells both own brands and products from leading suppliers in advanced surgery such as laparoscopy and endoscopy, urology, thoracic medicine, and gynecology.”
Schoenherr’s team was led by Partner Christian Herbst and Counsel Maximilian Lang and included Associate Maximilian Nutz and Attorney Teresa Waidmann.